Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials

Psychopharmacology

Volumn 164, Issue 3, 2002, Pages 301-308

  Kasper, S ^a   Dienel, A ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

Cluster analysis; Efficacy; Hamilton Rating Scale for Depression; Hypericum extract; Meta analysis; Therapeutic profile

Indexed keywords

HYPERICUM EXTRACT; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ANXIETY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CLUSTER ANALYSIS; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; HUMAN; INSOMNIA; META ANALYSIS; OUTPATIENT; PRIORITY JOURNAL; SCORING SYSTEM; TIME; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CLUSTER ANALYSIS; DEPRESSION; FEMALE; HUMANS; HYPERICUM; MALE; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036430146     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1203-2     Document Type: Article

References (39)

1. Angst J, Scheidegger P, Stabl M (1993) Efficacy of moclobemide in different patient groups. Results of new subscales of the Hamilton Depression Rating Scale. Clin Neuropharmacol 16:S55-S62
2. Ansseau M, Devoitille JM, Papart P, Vanbrabant E, Mantanus H, Timsit-Berthier M (1991) Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation. J Clin Psychopharmacol 11:160-165
3. Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bowling TG (1975) Quantitative rating of depressive states. Acta Psychiatr Scand 51:161-170
4. Berrios GE, Bulbena-Villarasa A (1990) The Hamilton depression scale and the numerical description of the symptoms of depression. In: Bech P, Coppen A (eds) The Hamilton Scales (Psychopharmacology Series, vol 9). Springer, Berlin
5. Brevoort P (1998) The booming US botanical market. Herbal Gram 44:33-48
6. Cureton EE, d'Agostino RB (1997) Factor analysis. Erlbaum, New York
7. De Smet PAGM, Nolen WA (1996) St. John's wort as an antidepressant. BMJ 313:241-242
8. Deltitio J, Beyer D (1998) The scientific, quasi-scientific and popular literature on the use of St. John's wort in the treatment of depression. J Affect Disord 51: 345-351
9. Ernst E (1995) St. John's wort, an anti-depressant? A systematic, criteria-based review. Phytomedicine 2:67-71
10. Ernst E, Rand JI, Barnes J, Stevinson C (1998) Adverse effects profile of the herbal antidepressant St John's wort (Hypericum perforatum L.). Eur J Clin Pharmacol 54:589-594
11. Everitt BS, Landau S, Morven L (2001) Cluster Analysis. Oxford University Press, New York
12. Feighner JP, Overo K (1999) Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. J Clin Psychiatry 60: 824-830
13. Fleck MP, Poirier-Littre MF, Guelfi JD, Bourdel MC, Loo H (1995) Factorial structure of the 17-item Hamilton Depression Rating Scale. Acta Psychiatr Scand 92:168-172
14. Friede T, Kieser M, Miller F (2000) Modeling the recovery from depressive illness by an exponential model with mixed effects. Methods Inf Med 39:12-15
15. Gagiano CA, Mueller FG, Berk M, Joubert PM, Brown RG, Schall R (1995) Moclobemide twice daily in the treatment of major depressive episode: A double-blind, multicenter comparison with different three times daily dosage schedules. J Clin Psychopharmacol 15:4S-9S
16. Guy W (1976) ECDEU Assessment Manual. Department of Health, Education and Welfare (DHEW Publication No. (ADM) 76-338) Washington, D.C.
17. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:66-62
18. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296
19. Hamilton M (1986) The Hamilton rating scale for depression. In Sartorius N, Ban TA (eds) Assessment of Depression. Springer, Berlin
20. Harrison P (1998) Herbal medicine takes root in Germany. CMAJ 158:637-639
21. Hedlund JL, Vieweg BW (1979) The Hamilton rating scale for depression: A comprehensive review. J Operational Psychiatry 10:149-165
22. Hypericum Depression Trial Study Group (2002) Effect of Hypericum perforatum (St John's wort) in major depressive disorder. JAMA 287:1807-1814
23. Kalb R, Trautmann-Sponsel RD, Kieser M (2001) Efficacy and tolerability of Hypericum extract WS®5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial. Pharmacopsychiatry 34:96-103
24. Kasper S, Trautmann-Sponsel RD (2001) St John's wort extract: An effective and well-tolerated antidepressant. Primary Care Psychiatry 7:39-42
25. Kasper S, Möller HJ, Montgomery SA, Zondag E (1995) Antidepressant efficacy in relation to item analysis and severity of depression: A placebo-controlled trial of fluvoxamine versus imipramine. Int Clin Psychopharmacol 9:3-12
26. Kim HL, Streltzer J, Goebert D (1999) St John's wort for depression - A meta-analysis of well-defined clinical trials. J Nerv Ment Dis 187:532-539
27. Laakmann G, Schüle C, Baghai T, Kieser M (1998a) St John's wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31:54-59
28. Laakmann G, Schüle C, Baghai T, Dienel A, Kieser M (1998b) Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities. Phytomedicine 5:435-442
29. Lecrubier Y (2001) Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities. Eur Neuropsychopharmacol 11:105-106
30. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D (1996) St John's wort for depression - An overview and meta-analysis of randomized clinical trials. BMJ 313:253-258
31. McDowell I, Newell C (1996) Measuring Health: A Guide to Rating Scales and Questionnaires. Oxford University Press, New York, pp 238-286
32. Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389
33. Priest RG, Hawley CJ, Kibel D, Kurian T, Montgomery SA, Patel AG, Smeyatsky N, Steinert J (1996) Recovery from depressive illness does fit an exponential model. J Clin Psychopharmacol 16:420-424
34. Prusoff BA, Weissman MM, Tanner J, Lieb J (1976) Symptom reduction in depressed outpatients treated with amitriptyline or maprotiline: Repeated measurement analysis. Comp Psychiatry 17:749-754
35. Rickels K, Chung HR, Feldman HS, Gordon PE, Kelly EA, Weise CC (1973) Amitriptyline, diazepam, and phenobarbital sodium in depressed outpatients. J Nerv Ment Dis 157:442-451
36. Schwab JJ, Bialow MR, Holzer CE (1976) A comparison of 2 rating scales for depression. J Clin Psychol 23:94-96
37. Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U (2001) Effectiveness of St John's wort in major depression. A randomized controlled trial. JAMA 285:1978-1986
38. Simon GE, Heiligenstein JH, Grothaus L, Katon W, Revicki D (1998) Should anxiety and insomnia influence antidepressant selection: A randomized comparison of fluoxetine and imipramine. J Clin Psychiatry 59:49-55
39. Volz HP (1997) Controlled clinical trials of Hypericum extracts in depressed patients - An overview. Pharmacopsychiatry 30:102-107